Autolus Therapeutics (AUTL) Non-Current Debt (2017 - 2019)
Autolus Therapeutics' (AUTL) quarterly Non-Current Debt came in at $30000.0 in Q3 2019, down 92.11% YoY from $380000.0 in Q3 2018, and down 75.21% on a QoQ basis from $121000.0 in Q2 2019.
Autolus Therapeutics (AUTL) Non-Current Debt (2017 - 2019) Analysis & Trends
Autolus Therapeutics (AUTL) has 3 years of Non-Current Debt data on file, last reported at $30000.0 in Q3 2019.
- Quarterly Non-Current Debt fell 92.11% year-over-year to $30000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $30000.0 (down 92.11% YoY) and the FY2019 annual result came in at $30000.0, down 92.11% from the prior year.
- Non-Current Debt eased to $30000.0 in Q3 2019, from $121000.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $763000.0 in Q3 2017 to a low of $30000.0 in Q3 2019.
- A 3-year average of $315800.0 and a median of $285000.0 in 2018 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2018 — Non-Current Debt plunged 50.2% — and 2019, when it tumbled 92.11%.
- Tracing AUTL's Non-Current Debt over 3 years: stood at $763000.0 in 2017, then tumbled by 62.65% to $285000.0 in 2018, then tumbled by 89.47% to $30000.0 in 2019.
- The last three Non-Current Debt figures came in at $30000.0 (Q3 2019), $121000.0 (Q2 2019), and $285000.0 (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 30,000.00 |
| Jun 30, 2019 | 121,000.00 |
| Dec 31, 2018 | 285,000.00 |
| Sep 30, 2018 | 380,000.00 |
| Sep 30, 2017 | 763,000.00 |